Peter Baumgarten

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 854 citations · Full text

Medicine, Molecular Biology, Pathology +16

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah et al. · Neuro-Oncology · 2019 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +17

Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma

Alexander Scholz, Patrick N. Harter, Sebastian Cremer et al. · EMBO Molecular Medicine · 2015 · 170 citations · Full text

Medicine, Neurology, Oncology +17

Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas

Pia S. Zeiner, Anna Golebiewska, Jenny Zinke et al. · Brain Pathology · 2018 · 163 citations · Full text

Life Sciences, Immunology, Oncology +17

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah Katz, Thomas Hielscher, Benjamin Liechty et al. · Acta Neuropathologica · 2018 · 162 citations

Life Sciences, Molecular Biology, Oncology +14